PREoPerAtive pREhabilitation in Patients With Head and Neck Cancer or Liver Cancer (PREPARE) (PREPARE)

May 9, 2023 updated by: Roeland F. de Wilde, Erasmus Medical Center
The objective of this study is to determine the feasibility (main aim) and effectiveness (secondary aim) of a prehabilitation program in patients with head and neck cancer or liver cancer. Participating patients will participate in a 3-to-6 week rehabilitation program consisting of training and nutritional, smoking cessation and psychosocial counselling.

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

In patients diagnosed with head and neck cancer (HNC) or liver cancer, (major) surgery is the standard of care. Nevertheless, surgery may result in complications that have a substantial impact on the physical and psychological state of the patient. Detrimental postoperative outcomes are influenced by unhealthy lifestyle behaviors such as a sedentary lifestyle, smoking and malnutrition. Prehabilitation programs focusing on these lifestyle aspects have been suggested as a promising intervention to improve pre- and postoperative outcomes. Therefore, the obective of this study is to determine the feasibility (main aim) and effectiveness (secondary aim) of a prehabilitation program in patients with HNC or liver cancer

This study concerns a prospective cohort study in 60 patients with HNC or liver cancer that participate in a 3 to 6-week pilot prehabilitation program consisting of training and nutritional, smoking cessation and psychosocial counselling.

Data on feasibility (program satisfaction, program compliance and percentage of patients willing to participate in the prehabilitation program) and effectiveness (e.g. complications, health status, compliance to healthy lifestyle) is collected at three time points (pre- and post the prehabilitation program and 30 days post-surgery).

Study Type

Interventional

Enrollment (Anticipated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • South Holland
      • Rotterdam, South Holland, Netherlands, 3000CA

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age ≥18 years
  • Diagnosis of head and neck cancer or liver cancer
  • Scheduled for surgery in Erasmus MC
  • Provision of written informed consent
  • Only patient with a waiting time of at least 3 weeks till surgery can participate in this study

Exclusion Criteria:

  • Patients that do not understand the Dutch language
  • Patients with severe physical or psychological comorbidities that limit participation in the prehabilitation program

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Prehabilitation
A 3-to-6-week prehabilitation program consisting of training and nutritional, smoking cessation and psychosocial counselling.

The prehabilitation program consists of 4 components:

  1. Fitness training led by a physiotherapist. The patients will receive personalized training schedules to perform at home. The training sessions focus on improving aerobic fitness (biking or walking) and muscle strength (specific exercises for the different patient groups) and respiratory exercises aimed to relax.
  2. Nutritional counseling led by a dietician. All patients will be offered an intake with a dietician (60 min) to discuss current eating habits and give personalized advices. Based on indication, patients will receive follow-up consults.
  3. Smoking cessation counseling led by a trained social worker. For patients that are currently smoking, a social worker will offer counseling sessions to coach the patient in the process of smoking cessation.
  4. Psychosocial counseling led by a psychologist. All patients will be offered counselling by a psychologist.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Program satisfaction
Time Frame: At completion of the prehabilitation program (3-6 weeks after baseline)
Self-designed questionnaire score (score between 1-10, higher score means higher satisfaction)
At completion of the prehabilitation program (3-6 weeks after baseline)
Program compliance
Time Frame: At completion of the prehabilitation program (3-6 weeks after baseline)
Number of sessions that patient participates in the fitness training, the counselling on nutrition, smoking cessation and psychosocial sessions will be registered.
At completion of the prehabilitation program (3-6 weeks after baseline)
Percentage of patients willing to participate in prehabilitation program
Time Frame: At completion of the prehabilitation program (3-6 weeks after baseline)
It will be registered which patient are willing and not willing to participate
At completion of the prehabilitation program (3-6 weeks after baseline)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Age
Time Frame: Baseline
Age in years
Baseline
Frailty
Time Frame: Outcomes will be collected twice: at baseline and at completion of the prehabilitation program (3-6 weeks after baseline)
Groningen Frailty Score questionnaire score: score of 0-15, a GFI score of four or greater is considered the cut-off point for frailty
Outcomes will be collected twice: at baseline and at completion of the prehabilitation program (3-6 weeks after baseline)
Length of hospital stay
Time Frame: 30 days post surgery
Registrered in patient file (length in days)
30 days post surgery
Complications Clavien Dindo grade ≥3 in first 30 days
Time Frame: 30 days post surgery
Registrered in patient file (number of complications and clavien dindo grade)
30 days post surgery
Readmission rate in first 30 days
Time Frame: 30 days post surgery
Number and reason for readmissions in first 30 days
30 days post surgery
Sex
Time Frame: Baseline
Female/male/other
Baseline
Medical diagnosis
Time Frame: Baseline
Medical diagnosis for surgery
Baseline
Educational level
Time Frame: Baseline
Single-item question (high, middle, low educated)
Baseline
Marital status
Time Frame: Baseline
Single-item question (Partnered/ unpartnered)
Baseline
Work status
Time Frame: Baseline
Single-item question (employed/unemployed)
Baseline
Functional capacity
Time Frame: At baseline and at completion of the prehabilitation program (3-6 weeks after baseline)
6-minute walk test: meters walked in 6 minutes time
At baseline and at completion of the prehabilitation program (3-6 weeks after baseline)
Physical activity level
Time Frame: At baseline and at completion of the prehabilitation program (3-6 weeks after baseline)
ActiGraph GTx3+ accelerometer: average time per day (min) spend in moderate-to-vigorous activity, light physical activity and sedentary behaviour
At baseline and at completion of the prehabilitation program (3-6 weeks after baseline)
Hand grip strength
Time Frame: At baseline and at completion of the prehabilitation program (3-6 weeks after baseline)
Hand dynamometer (kg)
At baseline and at completion of the prehabilitation program (3-6 weeks after baseline)
Quadriceps strength
Time Frame: At baseline and at completion of the prehabilitation program (3-6 weeks after baseline)
Biodex dynamometer (Peak torque to body weight extension + Work fatigue)
At baseline and at completion of the prehabilitation program (3-6 weeks after baseline)
Nutritional status
Time Frame: At baseline and at completion of the prehabilitation program (3-6 weeks after baseline)
Short Nutritional Assessment Questionnaire (SNAQ) score (range 4-20, lower score means higher risk of malnutrition)
At baseline and at completion of the prehabilitation program (3-6 weeks after baseline)
Body composition
Time Frame: At baseline and at completion of the prehabilitation program (3-6 weeks after baseline)
Weight scale (kg)
At baseline and at completion of the prehabilitation program (3-6 weeks after baseline)
Health status
Time Frame: At baseline, at completion of the prehabilitation program (3-6 weeks after baseline), 30 days post surgery
EuroQol-5D (EQ5D) questionnaire score (0-1, the maximum score of 1 indicates the best health state)
At baseline, at completion of the prehabilitation program (3-6 weeks after baseline), 30 days post surgery
Anxiety and Depression
Time Frame: At baseline and at completion of the prehabilitation program (3-6 weeks after baseline)
Hospital Anxiety and Depression Scale questionnaire score (0-21, higher scores denotes risk of anxiety or depression
At baseline and at completion of the prehabilitation program (3-6 weeks after baseline)
Self-efficacy
Time Frame: At baseline and at completion of the prehabilitation program (3-6 weeks after baseline)
General Self Efficacy Scale questionnaire score (10-40, with a higher score indicating more self-efficacy
At baseline and at completion of the prehabilitation program (3-6 weeks after baseline)
Self-reported smoking behaviour
Time Frame: At baseline and at completion of the prehabilitation program (3-6 weeks after baseline)
Self-designed questionnaire (smoking yes/no)
At baseline and at completion of the prehabilitation program (3-6 weeks after baseline)
Smoking behaviour
Time Frame: At baseline and at completion of the prehabilitation program (3-6 weeks after baseline)
carbon monoxide breath analyser (CO ppm + % COhb)
At baseline and at completion of the prehabilitation program (3-6 weeks after baseline)
Alcohol consumptiom
Time Frame: At baseline and at completion of the prehabilitation program (3-6 weeks after baseline)
Five shot questionnaire score (0-7, a higher score indicates possible alcohol misuse)
At baseline and at completion of the prehabilitation program (3-6 weeks after baseline)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2023

Primary Completion (Anticipated)

December 1, 2024

Study Completion (Anticipated)

July 1, 2025

Study Registration Dates

First Submitted

February 6, 2023

First Submitted That Met QC Criteria

February 15, 2023

First Posted (Actual)

February 27, 2023

Study Record Updates

Last Update Posted (Actual)

May 10, 2023

Last Update Submitted That Met QC Criteria

May 9, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer Head Neck

Clinical Trials on Prehabilitation

3
Subscribe